Navigation Links
Millions Of Diabetic And Glaucoma Patients Risk Blindness

More than 1.9 million diabetics and 250,000 early-stage glaucoma patients risk blindness due to lack of proper awareness according to a report published by the Royal National Institute for the Blind (RNIB).// In an attempt to prevent such a disaster, a campaign called 'Open Your Eyes' has been launched in the UK.

Apart from the above-mentioned figure, another 2 million are believed to suffer from some form of visual impairment in the UK. The organization has said that 50% of vision loss can be avoided if proper care is instituted at an early stage. It further highlights the need for promotion of such campaigns by the Government.

The role of vision tests in the early identification of should not be ignored. Although 9 out of 10 people confess about the fear of losing eyesight, 1 in 3 have not had a vision test over the past two years.

In addition, educating the ever-increasing diabetic population would pose a significant challenge in preserving the vision. The Government would have to be an active participant, if the task were to be accomplished successfully.

Unless and until such initiatives are taken, more than thousands of individuals, more specifically, the aging population would lose their valuable vision as a result of potentially treatable conditions.
'"/>




Page: 1

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
3. Decoding the Fungi Genome Will Save Millions of Lives.
4. Early Detection Of Primary Liver Cancer Would Save Millions Of Lives
5. WHO Attributes Death of Millions in Africa to Treatable diseases
6. Millions with Arthritis May Benefit from Bone Loss Drug
7. Toll of a Potential Flu Pandemic Runs into Millions
8. NHS Could Save Millions Through Generic Drugs
9. Glaucoma: Silently Stealing Sight from Millions
10. Easy Money-NHS Trusts Make Millions from Parking Fees
11. Ladakh was a Coastal Region Millions of Years Ago
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: